Cargando…
Differential and Conditional Activation of PKC-Isoforms Dictates Cardiac Adaptation during Physiological to Pathological Hypertrophy
A cardiac hypertrophy is defined as an increase in heart mass which may either be beneficial (physiological hypertrophy) or detrimental (pathological hypertrophy). This study was undertaken to establish the role of different protein kinase-C (PKC) isoforms in the regulation of cardiac adaptation dur...
Autores principales: | Naskar, Shaon, Datta, Kaberi, Mitra, Arkadeep, Pathak, Kanchan, Datta, Ritwik, Bansal, Trisha, Sarkar, Sagartirtha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130596/ https://www.ncbi.nlm.nih.gov/pubmed/25116170 http://dx.doi.org/10.1371/journal.pone.0104711 |
Ejemplares similares
-
Role of α-crystallin B as a regulatory switch in modulating cardiomyocyte apoptosis by mitochondria or endoplasmic reticulum during cardiac hypertrophy and myocardial infarction
por: Mitra, A, et al.
Publicado: (2013) -
Differential Roles of the PKC Novel Isoforms, PKCδ and PKCε, in Mouse and Human Platelets
por: Pears, Catherine J., et al.
Publicado: (2008) -
Arginyltransferase knockdown attenuates cardiac hypertrophy and fibrosis through TAK1-JNK1/2 pathway
por: Singh, Kanika, et al.
Publicado: (2020) -
Author Correction: Arginyltransferase knockdown attenuates cardiac hypertrophy and fibrosis through TAK1-JNK1/2 pathway
por: Singh, Kanika, et al.
Publicado: (2020) -
PKC isoforms interact with and phosphorylate DNMT1
por: Lavoie, Geneviève, et al.
Publicado: (2011)